BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 16840197)

  • 1. Lipoprotein lipase expression is a novel prognostic factor in B-cell chronic lymphocytic leukemia.
    Nückel H; Hüttmann A; Klein-Hitpass L; Schroers R; Führer A; Sellmann L; Dührsen U; Dürig J
    Leuk Lymphoma; 2006 Jun; 47(6):1053-61. PubMed ID: 16840197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The LPL/ADAM29 expression ratio is a novel prognosis indicator in chronic lymphocytic leukemia.
    Oppezzo P; Vasconcelos Y; Settegrana C; Jeannel D; Vuillier F; Legarff-Tavernier M; Kimura EY; Bechet S; Dumas G; Brissard M; Merle-Béral H; Yamamoto M; Dighiero G; Davi F;
    Blood; 2005 Jul; 106(2):650-7. PubMed ID: 15802535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lipoprotein lipase and serum thymidine kinase level in chronic lymphocytic leukemia and their correlations with other prognostic factors].
    Xu W; Shen QD; Yu H; Qiao C; Wu YJ; Liu Q; Zhu DX; Miao KR; Li JY
    Zhonghua Xue Ye Xue Za Zhi; 2009 Jan; 30(1):8-12. PubMed ID: 19563027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression level of lipoprotein lipase in Chinese patients with chronic lymphocytic leukemia and its correlation with other prognostic factors.
    Xu W; Li JY; Shen QD; Wu YJ; Yu H; Fan L
    Int J Lab Hematol; 2009 Oct; 31(5):552-9. PubMed ID: 18616755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The predictive value of lipoprotein lipase for survival in chronic lymphocytic leukemia.
    van't Veer MB; Brooijmans AM; Langerak AW; Verhaaf B; Goudswaard CS; Graveland WJ; van Lom K; Valk PJ
    Haematologica; 2006 Jan; 91(1):56-63. PubMed ID: 16434371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IGHV gene mutational status and LPL/ADAM29 gene expression as clinical outcome predictors in CLL patients in remission following treatment with oral fludarabine plus cyclophosphamide.
    Maloum K; Settegrana C; Chapiro E; Cazin B; Leprêtre S; Delmer A; Leporrier M; Dreyfus B; Tournilhac O; Mahe B; Nguyen-Khac F; Lesty C; Davi F; Merle-Béral H
    Ann Hematol; 2009 Dec; 88(12):1215-21. PubMed ID: 19340428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia.
    Heintel D; Kienle D; Shehata M; Kröber A; Kroemer E; Schwarzinger I; Mitteregger D; Le T; Gleiss A; Mannhalter C; Chott A; Schwarzmeier J; Fonatsch C; Gaiger A; Döhner H; Stilgenbauer S; Jäger U;
    Leukemia; 2005 Jul; 19(7):1216-23. PubMed ID: 15858619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [ZAP-70 expression in 24 patients with B cell chronic lymphocytic leukemia].
    Wu YJ; Li JY; Zhu GR; Song JH; Xiao B
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):237-40. PubMed ID: 16638188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deregulated expression of fat and muscle genes in B-cell chronic lymphocytic leukemia with high lipoprotein lipase expression.
    Bilban M; Heintel D; Scharl T; Woelfel T; Auer MM; Porpaczy E; Kainz B; Kröber A; Carey VJ; Shehata M; Zielinski C; Pickl W; Stilgenbauer S; Gaiger A; Wagner O; Jäger U;
    Leukemia; 2006 Jun; 20(6):1080-8. PubMed ID: 16617321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry method.
    Gachard N; Salviat A; Boutet C; Arnoulet C; Durrieu F; Lenormand B; Leprêtre S; Olschwang S; Jardin F; Lafage-Pochitaloff M; Penther D; Sainty D; Reminieras L; Feuillard J; Béné MC;
    Haematologica; 2008 Feb; 93(2):215-23. PubMed ID: 18223290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of LPL gene expression in patients with chronic lymphocytic leukemia.
    Bilous N; Abramenko I; Chumak A; Dyagil I; Martina Z
    Exp Oncol; 2019 Mar; 41(1):39-45. PubMed ID: 30932419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.
    Schroers R; Griesinger F; Trümper L; Haase D; Kulle B; Klein-Hitpass L; Sellmann L; Dührsen U; Dürig J
    Leukemia; 2005 May; 19(5):750-8. PubMed ID: 15759031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein lipase is differentially expressed in prognostic subsets of chronic lymphocytic leukemia but displays invariably low catalytical activity.
    Mansouri M; Sevov M; Fahlgren E; Tobin G; Jondal M; Osorio L; Roos G; Olivecrona G; Rosenquist R
    Leuk Res; 2010 Mar; 34(3):301-6. PubMed ID: 19709746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression level of lipoprotein lipase and dystrophin genes predict survival in B-cell chronic lymphocytic leukemia.
    Nikitin EA; Malakho SG; Biderman BV; Baranova AV; Lorie YY; Shevelev AY; Peklo MM; Vlasik TN; Moskalev EA; Zingerman BV; Vorob'ev IA; Poltaraus AB; Sudarikov AB; Vorobjev AI
    Leuk Lymphoma; 2007 May; 48(5):912-22. PubMed ID: 17487735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia.
    Dürig J; Nückel H; Cremer M; Führer A; Halfmeyer K; Fandrey J; Möröy T; Klein-Hitpass L; Dührsen U
    Leukemia; 2003 Dec; 17(12):2426-34. PubMed ID: 14523469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LPL gene expression is associated with poor prognosis in CLL and closely related to NOTCH1 mutations.
    Kristensen L; Kristensen T; Abildgaard N; Royo C; Frederiksen M; Mourits-Andersen T; Campo E; Møller MB
    Eur J Haematol; 2016 Aug; 97(2):175-82. PubMed ID: 26558352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LPL protein in Chronic Lymphocytic Leukaemia have different origins in Mutated and Unmutated patients. Advances for a new prognostic marker in CLL.
    Prieto D; Seija N; Uriepero A; Souto-Padron T; Oliver C; Irigoin V; Guillermo C; Navarrete MA; Inés Landoni A; Dighiero G; Gabus R; Giordano M; Oppezzo P
    Br J Haematol; 2018 Aug; 182(4):521-525. PubMed ID: 29953583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CLLU1 expression levels predict time to initiation of therapy and overall survival in chronic lymphocytic leukemia.
    Buhl AM; Jurlander J; Geisler CH; Pedersen LB; Andersen MK; Josefsson P; Petersen JH; Leffers H
    Eur J Haematol; 2006 Jun; 76(6):455-64. PubMed ID: 16529606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status.
    Hüttmann A; Klein-Hitpass L; Thomale J; Deenen R; Carpinteiro A; Nückel H; Ebeling P; Führer A; Edelmann J; Sellmann L; Dührsen U; Dürig J
    Leukemia; 2006 Oct; 20(10):1774-82. PubMed ID: 16932341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ZAP-70 expression, as detected by immunohistochemistry on bone marrow biopsies from early-phase CLL patients, is a strong adverse prognostic factor.
    Zanotti R; Ambrosetti A; Lestani M; Ghia P; Pattaro C; Remo A; Zanetti F; Stella S; Perbellini O; Prato G; Guida G; Caligaris-Cappio F; Menestrina F; Pizzolo G; Chilosi M
    Leukemia; 2007 Jan; 21(1):102-9. PubMed ID: 17082778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.